Ob.Gyn. NewsExteNET: Benefit of extended neratinib in HER2+ breast cancer sustainedOctober 16, 2017Breast Cancer
Ob.Gyn. NewsHER2 status differed between primary tumor and CTCs in 18.8% of women with MBCSeptember 28, 2017Breast Cancer
OBG ManagementBreast density and optimal screening for breast cancerSeptember 26, 2017Breast CancerGynecologic CancerGynecology
Ob.Gyn. NewsGEICAM/2006-10: Adjuvant fulvestrant/anastrozole role in early breast cancer uncertainSeptember 25, 2017Breast Cancer
Ob.Gyn. News‘Very daring study’ of neoadjuvant AI/CDKi combo in early BC is hypothesis generatingSeptember 23, 2017Breast Cancer
Ob.Gyn. NewsMONARCH 3: Abemaciclib plus AI boosts PFS in HR+/HER2- breast cancerSeptember 19, 2017Breast Cancer
Ob.Gyn. NewsLORELEI sings praises of neoadjuvant taselisib/letrozole in ER+/HER2– breast cancerSeptember 15, 2017Breast Cancer
Ob.Gyn. NewsSurgeons strongly influenced chances of contralateral prophylactic mastectomySeptember 13, 2017Breast Cancer
Ob.Gyn. NewsTen-year outcomes support skipping axillary lymph node dissection with positive sentinel nodesSeptember 12, 2017Breast Cancer
Ob.Gyn. NewsFDA clears first 2D mammography device with patient-controlled compressionSeptember 6, 2017Preventive CareBreast Cancer
OBG Management2017 Update on female sexual dysfunctionSeptember 1, 2017GynecologyMenopauseBreast CancerFemale Sexual DysfunctionOsteoporosis
Ob.Gyn. NewsFocus on lifestyle to manage menopause symptoms after breast cancerAugust 30, 2017MenopauseBreast Cancer
